US SB2740 | 2019-2020 | 116th Congress

US Congress Senate Bill 2740 (Prior Session Legislation)

Status

Spectrum: Bipartisan Bill
Status: Engrossed on December 11 2019 - 50% progression, died in committee
Action: 2019-12-14 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Engrossed) [PDF]

Summary

A bill to amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.

Title

Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019

Roll Calls

2019-12-10 - Senate - Passed Senate without amendment RC# 389 (Y: 91 N: 2 NV: 7 Abs: 0) [PASS]

History

Date	Chamber	Action
2019-12-14	House	Referred to the Subcommittee on Health.
2019-12-11	House	Referred to the House Committee on Energy and Commerce.
2019-12-11	House	Received in the House.
2019-12-11	Senate	Message on Senate action sent to the House.
2019-12-10	Senate	Passed Senate without amendment by Yea-Nay Vote. 91 - 2. Record Vote Number: 389. (consideration: CR S6921-6930; text: CR S6921-6930)
2019-11-05	Senate	Placed on Senate Legislative Calendar under General Orders. Calendar No. 290.
2019-11-05	Senate	Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander without amendment. Without written report.
2019-10-31	Senate	Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
2019-10-30	Senate	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Same As/Similar To

HB3443 (Related) 2019-07-24 - Sponsor introductory remarks on measure. (CR E971)
HB269 (Related) 2019-01-10 - Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 10.
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
HB748 (Related) 2020-07-23 - Committee on Small Business and Entrepreneurship. Hearings held.

Subjects

Administrative law and regulatory procedures
Administrative remedies
Child health
Congressional oversight
Cosmetics and personal care
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government information and archives
Government studies and investigations
Health
Inflation and prices
Judicial review and appeals
Marketing and advertising
User charges and fees

US Congress State Sources

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/senate-bill/2740/all-info
Text	https://www.congress.gov/116/bills/s2740/BILLS-116s2740is.pdf
Text	https://www.congress.gov/116/bills/s2740/BILLS-116s2740rs.pdf
Text	https://www.congress.gov/116/bills/s2740/BILLS-116s2740es.pdf
Roll Call	https://www.senate.gov/legislative/LIS/roll_call_votes/vote1161/vote_116_1_00389.htm